PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
19645854-5	2010	Pretreatment with zileuton partially prevented the AA-induced LTB(4) and IL-6 release and increased neutral lipid content.	zileuton	18-26	interleukin 6	Homo sapiens	73-77	
19645854-6	2010	IL-6 release and neutral lipid content were also reduced under long-term zileuton treatment.	zileuton	73-81	interleukin 6	Homo sapiens	0-4	
20436887-7	2009	Long-term treatment with Zileuton directly reduced the content of neutral lipids and interleukin-6 release from SZ95 seb ocytes.	zileuton	25-33	interleukin 6	Homo sapiens	85-98	
7496871-9	1995	Zileuton reduced TNF and IL-6 release, but enhanced IL-1 release.	zileuton	0-8	interleukin 6	Homo sapiens	25-29